Opdivo(纳武单抗)

[Opdivo (Nivolumab) Function and Indications]
1 Unresectable or metastatic melanoma
2 Metastatic squamous non-small cell lung cancer

[Model and Specification]
Injection: 40 mg/4 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL)

[Usage and Dosage]
The recommended dose of OPDIVO is 3 mg/kg given by intravenous infusion over 60 minutes every 2 weeks until disease progression or unacceptable toxicity.